BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Slaviero KA, Clarke SJ, Rivory LP. Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy. The Lancet Oncology 2003;4:224-32. [DOI: 10.1016/s1470-2045(03)01034-9] [Cited by in Crossref: 151] [Cited by in F6Publishing: 55] [Article Influence: 7.9] [Reference Citation Analysis]
Number Citing Articles
1 Trousil S, Lee P, Edwards RJ, Maslen L, Lozan-Kuehne JP, Ramaswami R, Aboagye EO, Clarke S, Liddle C, Sharma R. Altered cytochrome 2E1 and 3A P450-dependent drug metabolism in advanced ovarian cancer correlates to tumour-associated inflammation. Br J Pharmacol 2019;176:3712-22. [PMID: 31236938 DOI: 10.1111/bph.14776] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
2 Tsuchiya N, Yuasa T, Maita S, Narita S, Inoue T, Numakura K, Saito M, Satoh S, Yonese J, Habuchi T. Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinoma. BMC Urol 2014;14:26. [PMID: 24612599 DOI: 10.1186/1471-2490-14-26] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
3 Liu J, Chen Z, Chen H, Hou Y, Lu W, He J, Tong H, Zhou Y, Cai W. Genetic Polymorphisms Contribute to the Individual Variations of Imatinib Mesylate Plasma Levels and Adverse Reactions in Chinese GIST Patients. Int J Mol Sci 2017;18:E603. [PMID: 28335376 DOI: 10.3390/ijms18030603] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
4 Andrews LM, Hesselink DA, van Schaik RHN, van Gelder T, de Fijter JW, Lloberas N, Elens L, Moes DJAR, de Winter BCM. A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients. Br J Clin Pharmacol 2019;85:601-15. [PMID: 30552703 DOI: 10.1111/bcp.13838] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
5 Farge D, Frere C. Recent advances in the treatment and prevention of venous thromboembolism in cancer patients: role of the direct oral anticoagulants and their unique challenges. F1000Res 2019;8:F1000 Faculty Rev-974. [PMID: 31297188 DOI: 10.12688/f1000research.18673.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
6 Shi LX, Wang X, Wu Q, Sun X, Wan Z, Li L, Li K, Li X, Li Y, Zhang QY, Wu JP, Chen HY. Hepatic Cyp1a2 Expression Reduction during Inflammation Elicited in a Rat Model of Intermittent Hypoxia. Chin Med J (Engl) 2017;130:2585-90. [PMID: 29067957 DOI: 10.4103/0366-6999.217084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Tsuchiya H, Mizogami M. Interaction of local anesthetics with biomembranes consisting of phospholipids and cholesterol: mechanistic and clinical implications for anesthetic and cardiotoxic effects. Anesthesiol Res Pract 2013;2013:297141. [PMID: 24174934 DOI: 10.1155/2013/297141] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
8 Encalada Ventura MA, van Wanrooy MJ, Span LF, Rodgers MG, van den Heuvel ER, Uges DR, van der Werf TS, Kosterink JG, Alffenaar JW. Longitudinal Analysis of the Effect of Inflammation on Voriconazole Trough Concentrations. Antimicrob Agents Chemother 2016;60:2727-31. [PMID: 26883707 DOI: 10.1128/AAC.02830-15] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
9 Wijnant GJ, Van Bocxlaer K, Fortes Francisco A, Yardley V, Harris A, Alavijeh M, Murdan S, Croft SL. Local Skin Inflammation in Cutaneous Leishmaniasis as a Source of Variable Pharmacokinetics and Therapeutic Efficacy of Liposomal Amphotericin B. Antimicrob Agents Chemother 2018;62:e00631-18. [PMID: 30082295 DOI: 10.1128/AAC.00631-18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
10 Suno M, Endo Y, Nishie H, Kajizono M, Sendo T, Matsuoka J. Refractory cachexia is associated with increased plasma concentrations of fentanyl in cancer patients. Ther Clin Risk Manag 2015;11:751-7. [PMID: 26056457 DOI: 10.2147/TCRM.S79374] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Nakayama Y, Sugiyama A, Yamamoto T, Hyakudomi R, Hirahara N, Tajima Y. Pyomyositis in a Patient Undergoing Chemotherapy for Gastric Cancer: A Case Report and Literature Review. Case Rep Oncol 2021;14:1220-7. [PMID: 34703439 DOI: 10.1159/000518242] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Rendic S, Guengerich FP. Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters. Curr Drug Metab 2010;11:4-84. [PMID: 20302566 DOI: 10.2174/138920010791110917] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 6.3] [Reference Citation Analysis]
13 Creamer BA, Sloan SNB, Dennis JF, Rogers R, Spencer S, McCuen A, Persaud P, Staudinger JL. Associations between Pregnane X Receptor and Breast Cancer Growth and Progression. Cells 2020;9:E2295. [PMID: 33076284 DOI: 10.3390/cells9102295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 de Jong LM, Jiskoot W, Swen JJ, Manson ML. Distinct Effects of Inflammation on Cytochrome P450 Regulation and Drug Metabolism: Lessons from Experimental Models and a Potential Role for Pharmacogenetics. Genes (Basel) 2020;11:E1509. [PMID: 33339226 DOI: 10.3390/genes11121509] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Baker SD, Sparreboom A, Verweij J. Clinical pharmacokinetics of docetaxel : recent developments. Clin Pharmacokinet 2006;45:235-52. [PMID: 16509758 DOI: 10.2165/00003088-200645030-00002] [Cited by in Crossref: 118] [Cited by in F6Publishing: 102] [Article Influence: 7.4] [Reference Citation Analysis]
16 Naito T, Tashiro M, Yamamoto K, Ohnishi K, Kagawa Y, Kawakami J. Impact of cachexia on pharmacokinetic disposition of and clinical responses to oxycodone in cancer patients. Eur J Clin Pharmacol 2012;68:1411-8. [PMID: 22441315 DOI: 10.1007/s00228-012-1266-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
17 Fatunde OA, Brown SA. The Role of CYP450 Drug Metabolism in Precision Cardio-Oncology. Int J Mol Sci 2020;21:E604. [PMID: 31963461 DOI: 10.3390/ijms21020604] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
18 Maman A, Sahin A, Ayan AK. The Relationship of SUV Value in PET-CT with Tumor Differentiation and Tumor Markers in Gastric Cancer. Eurasian J Med 2020;52:67-72. [PMID: 32158318 DOI: 10.5152/eurasianjmed.2019.19016] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Lin M, Huang J, Zhu J, Shen H. Elevated pre-treatment levels of high sensitivity C-reactive protein as a potential prognosticator in patients with colorectal cancer. Exp Ther Med 2013;6:1369-74. [PMID: 24255664 DOI: 10.3892/etm.2013.1350] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
20 Li X, DuBois DC, Almon RR, Jusko WJ. Effect of Disease-Related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats. Drug Metab Dispos 2017;45:476-83. [PMID: 28246126 DOI: 10.1124/dmd.116.074500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
21 Tanaka H, Naito T, Sato H, Hiraide T, Yamada Y, Kawakami J. Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients. Eur J Clin Pharmacol 2018;74:1461-9. [PMID: 30051214 DOI: 10.1007/s00228-018-2527-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
22 Boyle CA, Coatney RW, Wickham A, Mukherjee SK, Meunier LD. Alpha-1 Acid Glycoprotein as a Biomarker for Subclinical Illness and Altered Drug Binding in Rats. Comp Med 2021;71:123-32. [PMID: 33789781 DOI: 10.30802/AALAS-CM-20-000088] [Reference Citation Analysis]
23 Bromwich E, McMillan DC, Lamb GW, Vasey PA, Aitchison M. The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer. Br J Cancer 2004;91:1236-8. [PMID: 15354220 DOI: 10.1038/sj.bjc.6602152] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
24 He X, Clarke SJ, McLachlan AJ. Clinical pharmacology of chemotherapy agents in older people with cancer. Curr Gerontol Geriatr Res 2011;2011:628670. [PMID: 21845189 DOI: 10.1155/2011/628670] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
25 Keller R, Klein M, Thomas M, Dräger A, Metzger U, Templin MF, Joos TO, Thasler WE, Zell A, Zanger UM. Coordinating Role of RXRα in Downregulating Hepatic Detoxification during Inflammation Revealed by Fuzzy-Logic Modeling. PLoS Comput Biol 2016;12:e1004431. [PMID: 26727233 DOI: 10.1371/journal.pcbi.1004431] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
26 Venuto CS, Lim J, Messing S, Hunt PW, McComsey GA, Morse GD. Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s. Antivir Ther 2018;23:345-51. [PMID: 29171837 DOI: 10.3851/IMP3209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer. 2004;90:1704-1706. [PMID: 15150622 DOI: 10.1038/sj.bjc.6601789] [Cited by in Crossref: 219] [Cited by in F6Publishing: 216] [Article Influence: 12.2] [Reference Citation Analysis]
28 Sadler NC, Webb-Robertson BM, Clauss TR, Pounds JG, Corley R, Wright AT. High-Fat Diets Alter the Modulatory Effects of Xenobiotics on Cytochrome P450 Activities. Chem Res Toxicol 2018;31:308-18. [PMID: 29688711 DOI: 10.1021/acs.chemrestox.8b00008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
29 Al Lawati Y, Cools-Lartigue J, Ramirez-GarciaLuna JL, Molina-Franjola JC, Pham D, Skothos E, Mueller C, Spicer J, Ferri L. Dynamic Alteration of Neutrophil-to-Lymphocyte Ratio over Treatment Trajectory is Associated with Survival in Esophageal Adenocarcinoma. Ann Surg Oncol 2020;27:4413-9. [PMID: 32363513 DOI: 10.1245/s10434-020-08521-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
30 Graham RA, Lum BL, Cheeti S, Jin JY, Jorga K, Von Hoff DD, Rudin CM, Reddy JC, Low JA, Lorusso PM. Pharmacokinetics of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors: the role of alpha-1-acid glycoprotein binding. Clin Cancer Res 2011;17:2512-20. [PMID: 21300760 DOI: 10.1158/1078-0432.CCR-10-2736] [Cited by in Crossref: 75] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
31 Obrador E, Benlloch M, Pellicer JA, Asensi M, Estrela JM. Intertissue flow of glutathione (GSH) as a tumor growth-promoting mechanism: interleukin 6 induces GSH release from hepatocytes in metastatic B16 melanoma-bearing mice. J Biol Chem. 2011;286:15716-15727. [PMID: 21393247 DOI: 10.1074/jbc.m110.196261] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
32 Yuan SQ, Nie RC, Chen YM, Qiu HB, Li XP, Chen XJ, Xu LP, Yang LF, Sun XW, Li YF, Zhou ZW, Chen S, Chen YB. Glasgow Prognostic Score is superior to ECOG PS as a prognostic factor in patients with gastric cancer with peritoneal seeding. Oncol Lett 2018;15:4193-200. [PMID: 29541185 DOI: 10.3892/ol.2018.7826] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
33 Moschny N, Hefner G, Grohmann R, Eckermann G, Maier HB, Seifert J, Heck J, Francis F, Bleich S, Toto S, Meissner C. Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs-Influence of Smoking Behavior and Inflammation on Pharmacokinetics. Pharmaceuticals (Basel) 2021;14:514. [PMID: 34071813 DOI: 10.3390/ph14060514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Diao L, Li N, Brayman TG, Hotz KJ, Lai Y. Regulation of MRP2/ABCC2 and BSEP/ABCB11 expression in sandwich cultured human and rat hepatocytes exposed to inflammatory cytokines TNF-{alpha}, IL-6, and IL-1{beta}. J Biol Chem 2010;285:31185-92. [PMID: 20702406 DOI: 10.1074/jbc.M110.107805] [Cited by in Crossref: 43] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
35 Franken LG, Masman AD, de Winter BCM, Baar FPM, Tibboel D, van Gelder T, Koch BCP, Mathot RAA. Hypoalbuminaemia and decreased midazolam clearance in terminally ill adult patients, an inflammatory effect? Br J Clin Pharmacol 2017;83:1701-12. [PMID: 28177137 DOI: 10.1111/bcp.13259] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
36 Ueno T, Tsuchiya H, Mizogami M, Takakura K. Local anesthetic failure associated with inflammation: verification of the acidosis mechanism and the hypothetic participation of inflammatory peroxynitrite. J Inflamm Res 2008;1:41-8. [PMID: 22096346 DOI: 10.2147/jir.s3982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 0.2] [Reference Citation Analysis]
37 Kacevska M, Downes MR, Sharma R, Evans RM, Clarke SJ, Liddle C, Robertson GR. Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism. Clin Cancer Res 2011;17:3170-80. [PMID: 21498392 DOI: 10.1158/1078-0432.CCR-10-3289] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
38 Quetglas EG, Armuzzi A, Wigge S, Fiorino G, Barnscheid L, Froelich M, Danese S. Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment. Eur J Clin Pharmacol 2015;71:773-99. [PMID: 26008212 DOI: 10.1007/s00228-015-1862-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
39 Zhu L, Li X, Shen Y, Cao Y, Fang X, Chen J, Yuan Y. A new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Onco Targets Ther 2016;9:4879-86. [PMID: 27540301 DOI: 10.2147/OTT.S107279] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
40 Vallet-Regí M, Manzano M, Rodriguez-Mañas L, Checa López M, Aapro M, Balducci L. Management of Cancer in the Older Age Person: An Approach to Complex Medical Decisions. Oncologist 2017;22:335-42. [PMID: 28220025 DOI: 10.1634/theoncologist.2016-0276] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
41 Wang Y, Chen L, Zhang B, Song W, Zhou G, Xie L, Yu D. Pretreatment Inflammatory-Nutritional Biomarkers Predict Responses to Neoadjuvant Chemoradiotherapy and Survival in Locally Advanced Rectal Cancer. Front Oncol 2021;11:639909. [PMID: 33816284 DOI: 10.3389/fonc.2021.639909] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Sherwin J, Thompson E, Hill KD, Watt K, Lodge AJ, Gonzalez D, Hornik CP. Clinical pharmacology considerations for children supported with ventricular assist devices. Cardiol Young 2018;28:1082-90. [PMID: 29991374 DOI: 10.1017/S1047951118001075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
43 Blijlevens NM, Donnelly JP, Naber AH, Schattenberg AV, DePauw BE. A randomised, double-blinded, placebo-controlled, pilot study of parenteral glutamine for allogeneic stem cell transplant patients. Support Care Cancer 2005;13:790-6. [PMID: 16186995 DOI: 10.1007/s00520-005-0790-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
44 Sharma R, Cunningham D, Smith P, Robertson G, Dent O, Clarke SJ. Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO. BMC Cancer 2009;9:153. [PMID: 19450285 DOI: 10.1186/1471-2407-9-153] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
45 Sharma R, Kacevska M, London R, Clarke SJ, Liddle C, Robertson G. Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies. Br J Cancer 2008;98:91-7. [PMID: 18059400 DOI: 10.1038/sj.bjc.6604101] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
46 Kacevska M, Mahns A, Sharma R, Clarke SJ, Robertson GR, Liddle C. Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signalling. Pharm Res 2013;30:2270-8. [PMID: 23604979 DOI: 10.1007/s11095-013-1042-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
47 Smith GR, Missailidis S. Cancer, inflammation and the AT1 and AT2 receptors. J Inflamm (Lond) 2004;1:3. [PMID: 15813980 DOI: 10.1186/1476-9255-1-3] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 3.6] [Reference Citation Analysis]
48 Jabłoński S, Kozakiewicz M. Evaluation of recovery in iatrogenic evoked acute mediatinitis. Inflammation 2013;36:1055-63. [PMID: 23619916 DOI: 10.1007/s10753-013-9637-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
49 Roncato R, Angelini J, Pani A, Cecchin E, Sartore-Bianchi A, Siena S, De Mattia E, Scaglione F, Toffoli G. CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions. Int J Mol Sci 2020;21:E6350. [PMID: 32883002 DOI: 10.3390/ijms21176350] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
50 Crozier JE, McKee RF, McArdle CS, Angerson WJ, Anderson JH, Horgan PG, McMillan DC. The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer. Br J Cancer. 2006;94:1833-1836. [PMID: 16721360 DOI: 10.1038/sj.bjc.6603185] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
51 Jabłoński S, Kozakiewicz M. Proposal for a recovery prediction method for patients affected by acute mediastinitis. World J Emerg Surg 2012;7:11. [PMID: 22574625 DOI: 10.1186/1749-7922-7-11] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
52 Lin M, Huang J, Zhu J, Shen H. Elevated pre-treatment levels of high sensitivity C-reactive protein as a potential prognosticator in patients with colorectal cancer. Exp Ther Med. 2013;6:1369-1374. [PMID: 24255664 DOI: 10.3892/etm. 2013.1350] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Fan X, Ding X, Zhang QY. Hepatic and intestinal biotransformation gene expression and drug disposition in a dextran sulfate sodium-induced colitis mouse model. Acta Pharm Sin B 2020;10:123-35. [PMID: 31993311 DOI: 10.1016/j.apsb.2019.12.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
54 Li X, DuBois DC, Almon RR, Jusko WJ. Modeling Sex Differences in Pharmacokinetics, Pharmacodynamics, and Disease Progression Effects of Naproxen in Rats with Collagen-Induced Arthritis. Drug Metab Dispos 2017;45:484-91. [PMID: 28246127 DOI: 10.1124/dmd.116.074526] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
55 Mosaffa F, Kalalinia F, Lage H, Afshari JT, Behravan J. Pro-inflammatory cytokines interleukin-1 beta, interleukin 6, and tumor necrosis factor-alpha alter the expression and function of ABCG2 in cervix and gastric cancer cells. Mol Cell Biochem. 2012;363:385-393. [PMID: 22193459 DOI: 10.1007/s11010-011-1191-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
56 Plasencia-García BO, Rico-Rangel MI, Rodríguez-Menéndez G, Rubio-García A, Torelló-Iserte J, Crespo-Facorro B. Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases. Pharmacopsychiatry 2021. [PMID: 34171927 DOI: 10.1055/a-1492-3293] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Fujita I, Watanabe H, Ikegami K, Imafuku T, Ichimizu S, Chikamatsu M, Kobayashi K, Tanaka R, Yamada K, Maeda H, Maruyama T. Involvement of the Parathyroid Hormone-Related Protein on Changes in the CYP3A Expression in Cancer Cachexia. Mol Pharm 2021;18:4322-30. [PMID: 34734526 DOI: 10.1021/acs.molpharmaceut.1c00490] [Reference Citation Analysis]
58 Liu J, Jin X, Zhou F, Chen H, Wang W, Liu Y, Wang G, Hao K, Zhang J. Disrupted hepatic pentose phosphate pathway directly participates in and indirectly promotes CYP3A reduction: A new strategy for CYP3A-mediated drug hepatotoxicity. Br J Pharmacol 2020;177:1538-55. [PMID: 31670839 DOI: 10.1111/bph.14916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]